Our study shows that the H3.3G34W mutation is associated with alterations of the epigenetic landscape of the mutant osteoprogenitors which notably comprise osteoblast-specific enhancers, including that of SCUBE3, thereby implicating this mutation in the pathogenesis of GCT specifically and not in other tumours. Here, SCUBE3 is linked to neoplasm.